124 related articles for article (PubMed ID: 38905131)
1. The European psychiatric association (EPA) - early career psychiatrists committee survey on trainees' and early-career psychiatrists' attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment.
Schoretsanitis G; Correll CU; Agorastos A; Compaired Sanchez A; Erzin G; Grigoras RM; Grizelj Benussi M; Gondek TM; Guloksuz S; Højlund M; Jerotic S; Kilic O; Metaj E; Sidhu DS; Skandali N; Skuhareuski A; Tveito M; Wolthusen RPF; ; Chumakov E; de Filippis R
World J Biol Psychiatry; 2024 Jul; 25(6):342-351. PubMed ID: 38905131
[TBL] [Abstract][Full Text] [Related]
2. Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring.
Best-Shaw L; Gudbrandsen M; Nagar J; Rose D; David AS; Patel MX
Ther Drug Monit; 2014 Aug; 36(4):486-93. PubMed ID: 24384695
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.
Law S; Haddad PM; Chaudhry IB; Husain N; Drake RJ; Flanagan RJ; David AS; Patel MX
Ther Adv Psychopharmacol; 2015 Aug; 5(4):214-23. PubMed ID: 26301077
[TBL] [Abstract][Full Text] [Related]
4. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
Patel MX; Nikolaou V; David AS
Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
[TBL] [Abstract][Full Text] [Related]
5. Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics.
Rodday AM; Parsons SK; Correll CU; Robb AS; Zima BT; Saunders TS; Leslie LK
J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):90-3. PubMed ID: 24679174
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
[TBL] [Abstract][Full Text] [Related]
7. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
[TBL] [Abstract][Full Text] [Related]
8. Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
Sugawara N; Yasui-Furukori N; Yamazaki M; Shimoda K; Mori T; Sugai T; Suzuki Y; Someya T
PLoS One; 2014; 9(1):e86826. PubMed ID: 24466260
[TBL] [Abstract][Full Text] [Related]
9. Training in sleep medicine among European early career psychiatrists: a project from the European Psychiatric Association--Early Career Psychiatrists Committee.
Walls B; Kölkebeck K; Petricean-Braicu A; Lattova Z; Kuzman MR; Andlauer O
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S375-8. PubMed ID: 26417799
[TBL] [Abstract][Full Text] [Related]
10. Survey on barriers to psychiatrists' use of clozapine for young people in Scotland and suggestions for reducing these.
Walker G; Lang J; Smith H
PLoS One; 2024; 19(6):e0304996. PubMed ID: 38900758
[TBL] [Abstract][Full Text] [Related]
11. Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey.
Oguchi Y; Miyake N; Ando K
Neuropsychopharmacol Rep; 2024 Jun; 44(2):417-423. PubMed ID: 38634351
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring: perspectives of psychiatrists in Turkey.
Eryılmaz G; Hızlı Sayar G; Gül IG; Noyan CO; Özten E; Darçın AE; Yorbik Ö; Dilbaz N
Int J Psychiatry Clin Pract; 2015 Mar; 19(1):60-4. PubMed ID: 25363201
[TBL] [Abstract][Full Text] [Related]
13. Psychiatrists' attitude towards and knowledge of clozapine treatment.
Nielsen J; Dahm M; Lublin H; Taylor D
J Psychopharmacol; 2010 Jul; 24(7):965-71. PubMed ID: 19164499
[TBL] [Abstract][Full Text] [Related]
14. Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder: A Survey of Italian Psychiatrists.
Salvi V; Cerveri G; Aguglia A; Calò S; Corbo M; Martinotti G; Serafini G; Signorelli MS; Aguglia E; Amore M; Biggio G; DI Sciascio G; Mencacci C
J Psychiatr Pract; 2019 Jul; 25(4):318-327. PubMed ID: 31291215
[TBL] [Abstract][Full Text] [Related]
15. Attitudes of Croatian psychiatrists towards long-acting injectable antipsychotics.
Ciglar M; Bjedov S; Maleković H
Psychiatr Danub; 2016 Sep; 28(3):273-277. PubMed ID: 27658836
[TBL] [Abstract][Full Text] [Related]
16. Psychiatrists' and Psychiatry Residents' Attitudes Toward Transgender People.
Ali N; Fleisher W; Erickson J
Acad Psychiatry; 2016 Apr; 40(2):268-73. PubMed ID: 25743203
[TBL] [Abstract][Full Text] [Related]
17. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
[TBL] [Abstract][Full Text] [Related]
18. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
Jalenques I; Ortega V; Legrand G; Auclair C
Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
[TBL] [Abstract][Full Text] [Related]
19. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
Grover C; Monds L; Montebello M
Australas Psychiatry; 2023 Jun; 31(3):329-335. PubMed ID: 36753675
[TBL] [Abstract][Full Text] [Related]
20. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
Jaeger M; Rossler W
Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
